The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study
Open accessAbstract
BACKGROUND: Potentially modifiable risk factors including obesity, diabetes, hypertension, and smoking are associated with Alzheimer disease (AD) and represent promising targets for intervention. However, the causality of these associations is unclear. We sought to assess the causal nature of these associations using Mendelian randomization (MR). METHODS AND FINDINGS: We used SNPs associated with each risk factor as instrumental variables in MR analyses. We considered type 2 diabetes (T2D, NSNPs = 49), fasting glucose (NSNPs = 36), insulin resistance (NSNPs = 10), body mass index (BMI, NSNPs = 32), total cholesterol (NSNPs = 73), HDL-cholesterol (NSNPs = 71), LDL-cholesterol (NSNPs = 57), triglycerides (NSNPs = 39), systolic blood pressure (SBP, NSNPs = 24), smoking initiation (NSNPs = 1), smoking quantity (NSNPs = 3), university completion (NSNPs = 2), and years of education (NSNPs = 1). We calculated MR estimates of associations between each exposure and AD risk using an inverse-variance weighted approach, with summary statistics of SNP-AD associations from the International Genomics of Alzheimer's Project, comprising a total of 17,008 individuals with AD and 37,154 cognitively normal elderly controls. We found that genetically predicted higher SBP was associated with lower AD risk (odds ratio [OR] per standard deviation [15.4 mm Hg] of SBP [95% CI]: 0.75 [0.62-0.91]; p = 3.4 × 10(-3)). Genetically predicted higher SBP was also associated with a higher probability of taking antihypertensive medication (p = 6.7 × 10(-8)). Genetically predicted smoking quantity was associated with lower AD risk (OR per ten cigarettes per day [95% CI]: 0.67 [0.51-0.89]; p = 6.5 × 10(-3)), although we were unable to stratify by smoking history; genetically predicted smoking initiation was not associated with AD risk (OR = 0.70 [0.37, 1.33]; p = 0.28). We saw no evidence of causal associations between glycemic traits, T2D, BMI, or educational attainment and risk of AD (all p > 0.1). Potential limitations of this study include the small proportion of intermediate trait variance explained by genetic variants and other implicit limitations of MR analyses. CONCLUSIONS: Inherited lifetime exposure to higher SBP is associated with lower AD risk. These findings suggest that higher blood pressure--or some environmental exposure associated with higher blood pressure, such as use of antihypertensive medications--may reduce AD risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig 1 Mendelian randomization estimates of the association of systolic blood pressure with AD in individual ADGC studies and overall in ADGC, GERAD1, and IGAP. This figure shows MR estimates for the association of SBP-associated variants with AD in each of the participant studies in ADGC [24] and in GERAD1 [25] using individual SNP-level data compared to that observed in IGAP [12] using summary-level data. See S1 Text (supplemental results) for individual study name abbreviations.](https://figures.cochat.ai/paper-figures/93ec1ed369514e09ab69e37cc379cde9/associations-between-potentially-modifiable-risk-factors-and-alzheimer-disease-a-figure-1.jpg)
![Fig 2 Associations of the systolic blood pressure genetic score with quantitative traits in the EPIC-InterAct study. This figure shows the investigation of pleiotropic associations of genetic score for SBP with quantitative traits in the EPIC-InterAct study [26]. Effect sizes are expressed in SDs per SBP-raising allele. Analyses were adjusted for age, sex, center of recruitment, and subcohort status.](https://figures.cochat.ai/paper-figures/77208328cad54e2fb95f55e3d441e7ff/associations-between-potentially-modifiable-risk-factors-and-alzheimer-disease-a-figure-2.jpg)
![Fig 3 Association of the systolic blood pressure genetic score with systolic blood pressure by age stratum in the EPIC-InterAct subcohort. This figure shows the association between the genetic score for SBP and SBP in the EPIC-InterAct study by age stratum [26]. Analyses were adjusted for sex, center of recruitment, and subcohort status.](https://figures.cochat.ai/paper-figures/a6202231a2e1419b901bfc75dd8209c6/associations-between-potentially-modifiable-risk-factors-and-alzheimer-disease-a-figure-3.jpg)
![Fig 4 Associations of the systolic blood pressure genetic score with binary outcomes in the EPIC-InterAct study. This figure shows the investigation of pleiotropic associations of the genetic score for SBP with binary outcomes in the EPIC-InterAct study [26]. The OR per SBP-raising allele is shown.](https://figures.cochat.ai/paper-figures/f0f543d70ce04999b366a54a31fbe5d0/associations-between-potentially-modifiable-risk-factors-and-alzheimer-disease-a-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting previous research suggesting that use of blood pressure and diabetic medications may reduce the risk of Alzheimer’s disease120.”
From Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) · cites this paper as [120]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Their interpretation was that increased risk in the weight loss group was due to reverse causation, as people often lose weight before they develop dementia.”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [193]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“An IPD meta-analysis of 1.3 million people from 39 prospective cohort studies found that obesity was a risk factor for dementia in cohorts where baseline was >15 years before but appeared protective if <10 before dementia. 193”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [193]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
Faith, M. S., Carnell, S., & Kral, T. V. E. (2013) · Human Heredity · doi:10.1159/000353879 · Cited by 7,601
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · cited 17×
“SNPs included in each risk score, their associations estimated by the relevant consortium, and their association with AD (IGAP [12]).”
InfluentialSelf-citationHearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
Cited by
Items 101–200 of 203
Grace, C., Clarke, R., Goel, A., Farrall, M., Watkins, H. C., & Hopewell, J. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-25460-2 · Cited by 23
LITKOWSKI, E. M., Logue, M. W., Zhang, R., CHAREST, B. R., Lange, E. M., Hokanson, J. E., Lynch, J. A., Vujković, M., Phillips, L. S., Lange, L. A., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0105 · Cited by 21
Liu, J., Xiao, Y., Zheng, X., Cheng, Y., Zhang, S., Ma, Y., Jiang, Q., Wang, S., Li, C., & Shang, H. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13854 · Cited by 21
Lipids, lipoproteins, and apolipoproteins: Associations with cognition and dementia
Rasmussen, I. J., Luo, J. M., & Frikke‐Schmidt, R. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118614 · Cited by 22
Using Mendelian randomization to understand and develop treatments for neurodegenerative disease
Storm, C. S., Kia, D. A., Almramhi, M. M., & Wood, N. W. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa031 · Cited by 19
Hypertension Is Associated With an Earlier Age of Onset of Huntington's Disease
Schultz, J. L., Harshman, L. A., Langbehn, D. R., & Nopoulos, P. (2020) · Movement Disorders · doi:10.1002/mds.28062 · Cited by 19
Cerebral blood flow regulation and cognitive performance in hypertension
Monteiro, A., Castro, P., Pereira, G. R., Ferreira, C., Polónia, J. J., Lobo, M. F., & Azevedo, E. I. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241254680 · Cited by 25
Gregson, J., Qizilbash, N., Iwagami, M., Douglas, I., Johnson, M., Pearce, N. E., & Pocock, S. (2019) · European Journal of Neurology · doi:10.1111/ene.14030 · Cited by 22
Noble, A. J., Purcell, R. V., Adams, A. T., Lam, Y. K., Ring, P. M., Anderson, J. R., & Osborne, A. J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.831866 · Cited by 23
Keine, D., Walker, J. Q., Kennedy, B. K., & Sabbagh, M. N. (2018) · Current Aging Science · doi:10.2174/1874609811666181019101430 · Cited by 21
Impact of modifiable risk factors on Alzheimer's disease: A two-sample Mendelian randomization study
Wang, Z., Meng, L., Shen, L., & Ji, H. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.02.018 · Cited by 19
Gallego, R., Suárez-Montenegro, Z. J., Ibáñez, E., Herrero, M., Valdés, A., & Cifuentes, A. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.769218 · Cited by 19
Peters, R. K., Breitner, J. C. S., James, S., Jicha, G. A., Meyer, P., Richards, M., Smith, A. D., Yassine, H. N., Abner, E. L., Hainsworth, A. H., et al. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12202 · Cited by 25
Nordestgaard, A. T., Nordestgaard, B. G., Frikke‐Schmidt, R., Rasmussen, I. J., & Bojesen, S. E. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.03.022 · Cited by 20
James, S., Wong, A., Tillin, T., Hardy, R., Chaturvedi, N., & Richards, M. (2019) · Diabetologia · doi:10.1007/s00125-019-4949-3 · Cited by 15
Dementia prevention: the Mendelian randomisation perspective
Anderson, E. L., Davies, N. M., Korologou‐Linden, R., & Mika Kivimaki, B. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2023-332293 · Cited by 25
Reis, R. J. S., Ayyadevara, S., Ganne, A., Mainali, N., Balasubramaniam, M., Atluri, R., Pahal, S., Asante, J., Nagel, C., & Vallurupalli, S. (2024) · doi:10.59368/agingbio.20240028 · Cited by 16
Impact of metabolic dysfunction on cognition in humans
Rasmussen, I. J., Thomassen, J. Q., & Frikke‐Schmidt, R. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000723 · Cited by 15
Genetically-Predicted Adult Height and Alzheimer’s Disease
Larsson, S. C., Traylor, M., Burgess, S., & Markus, H. S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170528 · Cited by 17
Geoffroy, F., Traulsen, A., & Uecker, H. (2022) · Journal of The Royal Society Interface · doi:10.1098/rsif.2022.0045 · Cited by 12
Huang, C., Wei, Z., Zheng, N., Yan, J., Zhang, J., Ye, X., & Zhao, W. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14618 · Cited by 18
Zhang, Q., Xu, F., Wang, L., Zhang, W.-D., Sun, C.-Q., & Deng, H.-W. (2020) · Aging · doi:10.18632/aging.103983 · Cited by 13
Mackey-Alfonso, S. E., & Barrientos, R. M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70911 · Cited by 14
Yokoyama, A. S., Dunaway, K. W., Rutkowsky, J. M., Rutledge, J. C., & Milenković, D. (2018) · Food & Function · doi:10.1039/c7fo01602f · Cited by 12
Systematic identification of risk factors and drug repurposing options for Alzheimer's disease
Wu, C., Wu, L., Wang, J., Lin, L., Li, Y., Lu, Q. L., & Deng, H.-W. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12148 · Cited by 17
Causal Association between Circulating Metabolites and Dementia: A Mendelian Randomization Study
Li, H., Qiu, C.-S., Du, L., Tang, X.-L., Liao, D., Xiong, Z.-Y., Lai, S., Huang, H.-X., Kuang, L., Zhang, B., et al. (2024) · Nutrients · doi:10.3390/nu16172879 · Cited by 11
Jeong, S., Lin, L., Pascual‐Leone, Á., & Hsu, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251326107 · Cited by 14
Han, S., Lelieveldt, T., Sturkenboom, M., Biessels, G. J., & Ahmadizar, F. (2025) · Biomedicines · doi:10.3390/biomedicines13051095 · Cited by 15
Zeng, P., Yu, X., & Zhou, X. (2019) · Scientific Reports · doi:10.1038/s41598-019-44114-5 · Cited by 12
Dai, J., Xu, Y., Wang, T., & Zeng, P. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110700 · Cited by 10
Yan, D., Hu, B., Darst, B. F., Mukherjee, S., Kunkle, B. W., Deming, Y. K., Dumitrescu, L. C., Wang, Y., Naj, A. C., Kuzma, A. B., et al. (2023) · eLife · doi:10.7554/elife.91360 · Cited by 12
Self-citationBiases in GWAS – the dog that did not barkPreprint
Schooling, C. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/709063 · Cited by 13
Protein Biomarkers for the Diagnosis of Alzheimer’s Disease at Different Stages of Neurodegeneration
Pérez, M., Hernández, F., & Ávila, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186749 · Cited by 9
High Density Lipoproteins: Is There a Comeback as a Therapeutic Target?
von Eckardstein, A. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_536 · Cited by 13
Yan, D., Hu, B., Darst, B. F., Mukherjee, S., Kunkle, B. W., Deming, Y. K., Dumitrescu, L. C., Wang, Y., Naj, A. C., Kuzma, A. B., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/468306 · Cited by 9
Self-citationDisease-modifying vs symptomatic treatments: Splitting over lumping
Duque, K. R., Vizcarra, J. A., Hill, E. J., & Espay, A. J. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00020-5 · Cited by 9
Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer’s Disease
Handy, Á., Initiative, O. B. O. T. A. D. N., Lord, J., Green, R., Xu, J., Aarsland, D., Velayudhan, L., Hye, A., Dobson, R., & Proitsi, P. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210462 · Cited by 9
Self-citationAnderson, E. L., Wade, K. H., Hemani, G., Bowden, J., Korologou‐Linden, R., Smith, G. D., Ben‐Shlomo, Y., Howe, L. D., & Stergiakouli, E. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/127993 · Cited by 8
Serum triglycerides in Alzheimer’s disease: Relation to neuroimaging and CSF biomarkersPreprint
Bernath, M. M., Bhattacharyya, S., Nho, K. T., Barupal, D. K., Fiehn, O., Baillie, R., Risacher, S. L., Arnold, M., Jacobson, T. Y., Trojanowski, J. Q., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/441394 · Cited by 8
Pathways to Racial/Ethnic Inequalities in Dementia
Palms, J. D., Sol, K., & Zahodne, L. B. (2025) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-081423-032631 · Cited by 12
Zhu, Y., Guan, Y., Xiao, X., Jiao, B., Liao, X., Zhou, H., Liu, X., Qi, F., Peng, Q., Zhou, L., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1157051 · Cited by 8
Relationship between Insulin Levels and Nonpsychotic Dementia: A Systematic Review and Meta-Analysis
Pan, Q.-X., Li, X., Liu, Y.-Y., Wang, F.-F., Hou, Y., Bian, Q., Qiu, W., Yan, Z., Jiang, Y.-M., & Chen, J. (2017) · Neural Plasticity · doi:10.1155/2017/1230713 · Cited by 9
Kim, S., Kim, K., Nho, K. T., Myung, W., & Won, H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200671 · Cited by 7
(2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890425787.x17_neurocognitive_disorders · Cited by 10
Raised blood pressure and risk of dementia
Gregson, J., Qizilbash, N., & Pocock, S. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy912 · Cited by 6
Mobile Application for Monitoring and Preventing Cognitive Decline Through Lifestyle Intervention
Angelis, I., Alvanou, A. G., Avgoustis, N., Vergis, S., Zervopoulos, A., Malakopoulou, M., Bezas, K., Nikiforos, M. N., Papamichail, A., Stylidou, A., et al. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-78775-2_11 · Cited by 5
Working status and risk of Alzheimer's disease: A Mendelian randomization study
Zhao, J., Li, K., & Liao, X. (2022) · Brain and Behavior · doi:10.1002/brb3.2834 · Cited by 6
The Diabetic Brain and Dementia
Jellinger, K. A. (2015) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000193 · Cited by 5
Liu, X., Wu, P., Shen, L. H., Jiao, B., Liao, X., Wang, H., Peng, J., & Lin, Z. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.583695 · Cited by 5
Commentary: Using human genetics to guide the repurposing of medicines
Bovijn, J., Censin, J. C., Lindgren, C. M., & Holmes, M. V. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa015 · Cited by 4
Nordestgaard, L. T., Luo, J., Emanuelsson, F., Leyden, G. M., Sanderson, E. C. M., Smith, G. D., Christoffersen, M., Afzal, S., Benn, M., Nordestgaard, B. G., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf662 · Cited by 6
Causal association between insulin sensitivity index and Alzheimer's disease
Xu, F., Wu, S., Gao, S., Li, X., Huang, C., Chen, Y., Zhu, P., & Liu, G. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16254 · Cited by 4
Cognitive Impairment and the Diabetic Brain
Jellinger, K. A. (2015) · International Journal of Neurology and Neurotherapy · doi:10.23937/2378-3001/2/2/1033 · Cited by 4
Is it time to reconcile HDL with cardiovascular diseases and beyond? An update on a paradigm shift
Martinez, L. O., Ingueneau, C., & Genoux, A. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000705 · Cited by 4
HDL ‐Apolipoprotein in Alzheimer's Disease Revisited: From Periphery to CNS
Huang, Y., Tang, J., Chen, G., Wu, Q., Wang, Y., Chen, J., Chen, S., Liu, J., & Huang, X. (2025) · Aging Medicine · doi:10.1002/agm2.70008 · Cited by 4
Disentangling the relationship between glucose, insulin and brain health: A UK Biobank study
Mason, A. C., Fatih, N., Sofat, R., Rentsch, C. T., Smeeth, L. L., Bhaskaran, K., Chaturvedi, N., & Garfield, V. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70353 · Cited by 9
Lee, L., Walker, R. M., & Whiteley, W. N. (2022) · F1000Research · doi:10.12688/f1000research.121604.1 · Cited by 5
Body mass index and risk of dementia
Koch, M., & Jensen, M. K. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000478 · Cited by 3
Yang, Y., Kuo, K., Li, H., Shen, X., Chen, S.-D., Cui, M., Dong, Q., & Yu, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200773 · Cited by 3
Disentangling the Complex Relationship Between Hypertension and Dementia
Proitsi, P. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.02.005 · Cited by 3
Self-citationPrevention of Dementia—Thinking Beyond the Age and Amyloid Boxes
Seshadri, S. S. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.3785 · Cited by 3
Palmer, J. C., Hart, E. C., Anderson, E. L., Love, S., & Lawlor, D. A. (2025) · BMC Medicine · doi:10.1186/s12916-025-04295-5 · Cited by 3
Harish, P., Malerba, A., Kroon, R. H. M. J. M., Shademan, M., van Engelan, B., Raz, V., Popplewell, L. J., & Snowden, S. G. (2023) · Metabolites · doi:10.3390/metabo13060769 · Cited by 2
Lei, Q., Xiao, Z., Wu, W., Liang, X., Zhao, Q., Ding, D., & Deng, W. (2023) · The journal of nutrition health & aging · doi:10.1007/s12603-023-2027-5 · Cited by 2
Bourdonnec, K. L., Samieri, C., Tzourio, C., Mura, T., Mishra, A., Trégouët, D., & Proust‐Lima, C. (2023) · Biometrical Journal · doi:10.1002/bimj.202200358 · Cited by 3
Selection of invalid instruments can improve estimation in Mendelian randomizationPreprint
Patel, A. R., DiTraglia, F. J., Zuber, V., & Burgess, S. (2021) · arXiv (Cornell University) · Cited by 2
Editorial: Genetics of Age-Related Diseases and Their Risk and Protective Factors
Karlsson, I., Arpawong, T. E., Zhan, Y., & Lehto, K. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.771109 · Cited by 2
Lee, L., Walker, R. M., & Whiteley, W. N. (2022) · medRxiv · doi:10.1101/2022.02.23.22271334 · Cited by 1
Sargurupremraj, M., Soumaré, A., Bis, J. C., Surakka, I. L., Jürgenson, T., Joly, P., Knol, M. J., Wang, R., Yang, Q., Satizábal, C. L., et al. (2023) · medRxiv · doi:10.1101/2023.08.08.23293761 · Cited by 2
Desai, R., Heller, J., Wada, R., Afnan, M. A. M., Cheong, C., Zhang, S., Deo, F., Tam, M., Anderson, E. L., Stott, J. C. H., et al. (2025) · medRxiv · doi:10.1101/2025.03.12.25323830 · Cited by 2
Sarnowski, C., Zhang, Y., Ammous, F., Shade, L. M. P., DICORPO, D. A., Jian, X., Arnett, D. K., Austin, T. R., Beiser, A., Bis, J. C., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08674-9 · Cited by 2
Mirzai, M., Marouf, S. P., Eslami, M., & Nabian, M. H. (2026) · Metabolism Open · doi:10.1016/j.metop.2026.100474 · Cited by 1
Association of Cardiovascular Risk Factors and Stroke With Alzheimer Disease—Reply
Tosto, G., & Mayeux, R. P. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4384 · Cited by 1
Wu, C., Wu, L., Wang, J., Lin, L.-F., Li, Y.-M., Lu, Q., & Deng, H.-W. (2020) · medRxiv · doi:10.1101/2020.07.14.20153726
Yan, D., Hu, B., Darst, B. F., Mukherjee, S., Kunkle, B. W., Deming, Y. K., Dumitrescu, L. C., Wang, Y., Naj, A. C., Kuzma, A. B., et al. (2023) · eLife · doi:10.7554/elife.91360.1 · Cited by 1
Self-citationLorenzini, P. A., & Langley, S. R. (2024) · medRxiv · doi:10.1101/2024.05.30.24307732 · Cited by 1
ABCA1 activity is associated with reduced Alzheimer’s Disease risk in APOE ε4 non-carriersPreprint
Peña‐Tauber, A., Arriaza, R. H., Guen, Y. L., Park, J. Y., & Greicius, M. D. (2025) · medRxiv · doi:10.1101/2025.01.24.25321105 · Cited by 1
Glucose-Dementia Association Is Consistent Over Blood Pressure/Antihypertensive Groups
Zhou, J., Walker, R. L., Gray, S. L., Marcum, Z. A., Barthold, D., Bowen, J. D., McCormick, W. C., McCurry, S. M., Larson, E. B., & Crane, P. K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201138 · Cited by 1
Self-citationPattee, J. W. (2020) · University of Minnesota Digital Conservancy (University of Minnesota)
Dybjer, E., Kumar, A., Nägga, K., Engström, G., Mattsson, N., Nilsson, P. M., Melander, O., & Hansson, O. (2022) · Research Square · doi:10.21203/rs.3.rs-1996829/v1
Palmer, J. C., Hart, E. C., Anderson, E. L., Love, S., & Lawlor, D. A. (2024) · medRxiv · doi:10.1101/2024.10.17.24315654
Glucose, insulin, and brain health in the UK Biobank: A Mendelian randomisation studyPreprint
Garfield, V., Fatih, N., Rentsch, C. T., Smeeth, L. L., Bhaskaran, K., & Chaturvedi, N. (2025) · medRxiv · doi:10.1101/2025.02.10.25321985
Ou, Y.-N., Yang, Y.-X., Shen, X.-N., Ma, Y.-H., Chen, S.-D., Dong, Q., Tan, L., & Yu, J.-T. (2021) · Figshare · doi:10.6084/m9.figshare.13843888
Ou, Y.-N., Yang, Y.-X., Shen, X.-N., Ma, Y.-H., Chen, S.-D., Dong, Q., Tan, L., & Yu, J.-T. (2021) · Figshare · doi:10.6084/m9.figshare.13843879
Pillai, J. A., Bena, J., Bekris, L., Kodur, N., Kasumov, T., Leverenz, J. B., & Kashyap, S. R. (2024) · Figshare · doi:10.6084/m9.figshare.26575472
Ou, Y.-N., Yang, Y.-X., Shen, X.-N., Ma, Y.-H., Chen, S.-D., Dong, Q., Tan, L., & Yu, J.-T. (2021) · Figshare · doi:10.6084/m9.figshare.13843876
Pillai, J. A., Bena, J., Bekris, L., Kodur, N., Kasumov, T., Leverenz, J. B., & Kashyap, S. R. (2024) · Figshare · doi:10.6084/m9.figshare.26575466
Ou, Y.-N., Yang, Y.-X., Shen, X.-N., Ma, Y.-H., Chen, S.-D., Dong, Q., Tan, L., & Yu, J.-T. (2021) · Figshare · doi:10.6084/m9.figshare.13843867
Ou, Y.-N., Yang, Y.-X., Shen, X.-N., Ma, Y.-H., Chen, S.-D., Dong, Q., Tan, L., & Yu, J.-T. (2021) · Figshare · doi:10.6084/m9.figshare.13843861
Ou, Y.-N., Yang, Y.-X., Shen, X.-N., Ma, Y.-H., Chen, S.-D., Dong, Q., Tan, L., & Yu, J.-T. (2021) · Figshare · doi:10.6084/m9.figshare.13843864
Pillai, J. A., Bena, J., Bekris, L., Kodur, N., Kasumov, T., Leverenz, J. B., & Kashyap, S. R. (2024) · Figshare · doi:10.6084/m9.figshare.26575469
Ou, Y.-N., Yang, Y.-X., Shen, X.-N., Ma, Y.-H., Chen, S.-D., Dong, Q., Tan, L., & Yu, J.-T. (2021) · Figshare · doi:10.6084/m9.figshare.13843870
Ou, Y.-N., Yang, Y.-X., Shen, X.-N., Ma, Y.-H., Chen, S.-D., Dong, Q., Tan, L., & Yu, J.-T. (2021) · Figshare · doi:10.6084/m9.figshare.13843882
Ou, Y., Yang, Y.-X., Shen, X.-N., Ma, Y.-H., Chen, S.-D., Dong, Q., Tan, L., & Yu, J.-T. (2021) · Figshare · doi:10.6084/m9.figshare.13843885
Marqueurs périphériques de l'inflammation et déclin cognitif au cours de la maladie d'Alzheimer
Julian, A. (2018) · theses.fr (ABES) · doi:10.70675/0f58e0a1z28d9z40b7z886fz752caf42c261
Frison, É. (2019) · theses.fr (ABES) · doi:10.70675/a527bd03zb814z44e5z8848z942b662a0847 · Cited by 2
The influence of blood lipids on cerebral perfusion by apolipoprotein E status
Decker, K., Rizzi, N., Rigas, Z., Awad, C., Habash, E. M., Kramer, M. K., Cerjanic, A. M., Cohen, M. L., Johnson, C. L., & Martens, C. R. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101057
Luo, J., Rasmussen, I. J., Thomassen, J. Q., & Frikke‐Schmidt, R. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120824 · Cited by 1
de Leijer, J. F., Biessels, G. J., Visseren, F. L. J., & van Sloten, T. T. (2026) · Diabetologia · doi:10.1007/s00125-026-06795-2 · Cited by 1
Genetic Modifiers of ABCA1 Activity Interact with APOE Isoforms to Mediate Alzheimer's Disease Risk
Peña‐Tauber, A., Arriaza, R. H., Reil, D., Muntaner, M., Park, J. Y., Grenier‐Boley, B., Hulsman, M., Amouyel, P., Bellenguez, C., Charbonnier, C., et al. (2026) · Annals of Neurology · doi:10.1002/ana.78303
Metadata
- Authors
- Østergaard, S. D., Mukherjee, S., Sharp, S. J., Proitsi, P., Lotta, L. A., Day, F., Perry, J. R. B., Boehme, K. L., Walter, S., Kauwe, J. S., Gibbons, L. E., Alzheimer’s Disease Genetics Consortium, The GERAD1 Consortium, EPIC-InterAct Consortium, Larson, E. B., Powell, J. F., Langenberg, C., Crane, P. K., Wareham, N. J., & Scott, R. A.
- Affiliations
- Aarhus University (DK)
- University of Washington (US)
- University of Cambridge (GB)
- King's College London (GB)
- Brigham Young University (US)
- University of California, San Francisco (US)
- Kaiser Permanente Washington Health Research Institute (US)
- Corresponding author
- Scott, Robert A.
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-06-16
- Volume
- 12
- Issue
- 6
- Pages
- e1001841
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC4469461
- OpenAlex
- W605291159
- Cited by
- 203
- References
- 51
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 15 · 2023: 17 · 2022: 16 · 2021: 36 · 2020: 23 · 2019: 23 · 2018: 17 · 2017: 17 · 2016: 13 · 2015: 4
- FWCI
- 13.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Research Portal (Queen's University Belfast) (submittedVersion, cc-by)
- DiVA at Umeå University (Umeå University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Site cant be reached (submittedVersion, cc-by)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Funders
- Howard Hughes Medical Institute
- U.S. Department of Veterans Affairs (U01 AG024904)
- Juvenile Diabetes Research Foundation International
- Alzheimer's Association (IIRG-05–14147, K01 AG030514, U01 AG016976, U01 AG032984, IIRG-08-89720, U01 AG024904, U24AG021886)
- Dana Foundation (K01 AG030514, U01 AG024904)
- Bristol-Myers Squibb (U01 AG024904, AG024904)
- Eli Lilly and Company (U01 AG024904, AG024904)
- Pfizer (AG024904, 115372, U01 AG024904)
- AstraZeneca
- GlaxoSmithKline
- Novartis (FP7/2007-2013)
- Office of Research and Development
- F. Hoffmann-La Roche (AG024904, U01 AG024904)
- Medpace (U01 AG024904)
- Synarc (U01 AG024904, K01 AG030514)
- South London and Maudsley NHS Foundation Trust
- Wellcome Trust (FP7/2007–2013, 089703, 081864, 115372)
- European Federation of Pharmaceutical Industries and Associations (FP7/20072013, 115372)
- Alzheimer's Society
- Alzheimer's Research Trust
- National Institute for Health and Care Research (115372, NF-SI-0512-10033, FP7/2007–2013, K01 AG030514, U01 AG024904, NF-SI-0512-10135, CL-2011-18-004)
- University of Cambridge
- King's College London
- Newcastle University
- European Commission (U01 AG024904, LSHM_CT_2006_037197, 2007–2013, FP7 2007-2013, FP7/2007, 115372)
- Cardiff University
- Bundesministerium für Bildung und Forschung
- Stichting MS Research
- Elan (U01 AG024904)
- Lundbeckfonden (R165–2013–15320)
- Eisai (U01 AG024904, AG024904)
- North Bristol NHS Trust
- Alfried Krupp von Bohlen und Halbach-Stiftung
- Universitat de Barcelona
- Hersenstichting
- University College London Hospitals NHS Foundation Trust
- H. Lundbeck A/S (U01 AG024904, AG024904)
- Heinz Nixdorf Stiftung
- National Institutes of Health (5rc2ag036502-02, UL1TR001108, FP7/2007-2013, 5r01ag027944-05, 5u01ag024904-10, 7r01ag019757-06, 5r37ag015473-15, AG016976, U01-AG024904, AG024904, AG019610, AG021886, MH60451, U01 AG10483, AG10483, AG013846, UL1TR001445)
- Genentech (AG024904, U01 AG024904)
- Canadian Institutes of Health Research
- Medical Research Council (MR/L023784/2, FP7/20072013, MR/K006584/1, U01 AG024904, MC_PC_13048, MC_UU_12015/2, MR/L501529/1, MR/L010305/1, K01 AG030514, MC_UU_12015/1, MC_G1000734, MR/L023784/1)
- Economic and Social Research Council (ES/L008238/1)
- Menzies Centre for Australian Studies, King's College London, University of London
- Helmholtz Zentrum München
- National Institute on Aging (U01-AG-024904, R01AG017917, AG 10483, P01AG010491, P50 AG016575, AG 016976, AG05 128, P30AG010129, P30AG010133, R01AG019085, P30 AG 08051, P50AG005144, R01AG042611, U01‐AG10483, R01AG33193, P50 AG016576, R01AG030146, AG021547, R01 AG30146, AG036535, AG010491, R01‐AG17917, AG-05144, U24 AG026390, P30AG028383, R01 AG15819, P30AG012300, R01AG041718, AG 025688, P50AG016577, U01-AG-06781, P50AG005133, R01-AG027944, AG 024904, AG 030,514, P30AG028377, U01AG006781, U01AG016976, P50AG005131, R01-AG019757, R37-AG015473, P50AG005138, R01AG026390, AG041718, R01AG022374, P50AG016570, AG019610, K01AG030514, R01AG011101, AG036528, P50AG005128, P30AG010124, P50AG016573, AG019757, R01AG021547, R01AG041232, R01AG030653, U01AG010483, R01AG015819, P30AG008017, P30AG010161, U01AG032984, R01AG012101, CA129769, R01AG031581, P30AG008051, RC2-AG036502, P50AG016582, P50AG008702, AG032984, AG013846, AG-06781, P50AG005681, P50AG005142, P50AG008671, P30AG019610, R01AG026916, P50AG005146, P01 AG0 3991, P01AG003991, 1RC2AG036502, U24AG026395, P30AG013846, P50AG005136, P50AG005134, RC2AG036535, P30AG013854, R01AG025259, P50AG025688, AG026395, R01AG017173, RC2AG036528, R01AG033193, P01AG002219, AG021886, R01AG013616, P30 AG-10133, P01AG019724, U24AG021886, P30AG062421, P50AG023501, AG027944, R01AG020688, AG 030653, P50AG016574, R01AG035137, AG041232)
- National Institute of Mental Health (U01 AG024904, MH60451, R01MH080295, P50MH060451)
- National Human Genome Research Institute (U01HG008657, U01HG004610, U01HG006375)
- National Cancer Institute (R01CA129769, U54CA132378)
- National Institute of Allergy and Infectious Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Neurological Disorders and Stroke (NS3 9764, R01NS059873, MH60451, NIMH MH60451, P50NS039764, FP7/2007-2013)
- National Institute of Environmental Health Sciences (P30ES013508)
- National Institute of Biomedical Imaging and Bioengineering (U01 AG024904, AG024904)
- National Institute of Child Health and Human Development
- National Center for Research Resources (MO1 RR000-96, UL1RR02777, UL1RR029893, M01RR000096)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, modifiable risk factors, systolic blood pressure, smoking, type 2 diabetes, fasting blood glucose, insulin resistance, body mass index, serum lipids, cholesterol, triglycerides, antihypertensive drugs, educational attainment, causal inference, genetic variants, intervention targets, cognitive aging, dementia prevention, cardiovascular risk factors, glycemic traits
- MeSH terms
- Alzheimer Disease, Female, Humans, Male, Risk Factors, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.